Lung oncology Clinical Trials in Tampa, FL
As of August 2026, 43 paid clinical trials are recruiting for Lung oncology in Tampa, Florida. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Tampa
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
44 clinical trials for Lung oncology
·Clear filters·Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Top Research Study Locations in Tampa
Researchers run research studies in Tampa, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Moffitt Cancer Center | Breast Cancer, Ovarian Cancer, Pancreatic Cancer | 278 |
| University of South Florida | Heart Failure, Myasthenia Gravis, Stroke | 118 |
| Tampa General Hospital | Heart Failure, Kidney Transplant Rejection, Acute Myeloid Leukemia | 64 |
| Saint Joseph's Hospital/Children's Hospital-Tampa | Anatomic Stage II Breast Cancer AJCC v8, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | 36 |
| Moffitt Cancer Center - McKinley Campus | Stage IV Lung Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Anatomic Stage IV Breast Cancer AJCC v8 | 26 |
| Moffitt Cancer Center-International Plaza | Stage IV Lung Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Anatomic Stage IV Breast Cancer AJCC v8 | 21 |
| Moffit Cancer Center | Unresectable Metastatic Colorectal Cancer, Anemia, Esophageal Cancer | 15 |
| K2 Medical Research - Tampa | Alzheimer Disease, Plaque, Amyloid, Alcohol Use Disorder | 9 |
| St. Joseph's Children's Hospital | Ewing Sarcoma, Medulloblastoma, Neuroblastoma | 8 |
| GSK Investigational Site | Chickenpox, Gastrointestinal Neoplasms, HIV Infections | 7 |
| Neurocrine Clinical Site | Major Depressive Disorder, Schizophrenia, Tardive Dyskinesia | 7 |
| H. Lee Moffitt Cancer Center and Research Institute | Advanced Or Metastatic Merkel Cell Carcinoma, Angiosarcoma, Breast Cancer | 7 |
| USF Health | Epilepsy, Epilepsy (Treatment Refractory), Asthma | 7 |
| ForCare Clinical Research | Atopic Dermatitis, Cannabis Withdrawal, Eczema | 5 |
| GCP Clinical Research | Crohn Disease, Colitis, Ulcerative | 5 |
| IPTB Clinical Research | Agitation, Alzheimer Disease, Alzheimer's Disease | 5 |
| International Center for Research | C. Diff Infection, C.Difficile Diarrhea, CDI | 5 |
| Retina Associates of Florida, LLC | Age - Related Macular Degeneration (AMD), Age-Related Macular Degeneration, Choroidal Neovascularization | 5 |
| Retina Vitreous Associates of Florida | Age-Related Macular Degeneration, Choroidal Neovascularization, DME | 5 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, Generalized Myasthenia Gravis | 4 |
| AdventHealth Tampa | Heart Failure, ADHF, Cardio-Renal Syndrome | 4 |
| Clinical Research of West Florida | Acute Gout Flare, Arthritis, Arthritis, Psoriatic | 4 |
| Florida Orthopaedic Institute | Osteoarthritis, Carpal Tunnel Syndrome (CTS), Carpometacarpal (CMC) Joint Arthritis | 4 |
| Foundation for Orthopaedic Research and Education | Adhesive Capsulitis of Shoulder, Back Pain, Degenerative Disc Disease | 4 |
| H Lee Moffitt Cancer Center and Research Institute | Anaplastic Lymphoma Kinase-positive, KRAS G12C-mutated Solid Tumors, Lung Cancer, KRAS, NRAS, HRAS-mutated NSCLC | 4 |
Active & Upcoming Studies in Tampa (2026)
Recruiting trials in Tampa grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (385 active studies)
- Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy · Massachusetts General Hospital
- Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · Washington University School of Medicine
Neurology & pain (64 active studies)
- A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease · Phase 1 · Eli Lilly and Company
- A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease · Phase 1 · Eli Lilly and Company
Cardiovascular (51 active studies)
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
- A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults · Phase 1, Phase 2 · 35Pharma Inc
Diabetes & metabolic (28 active studies)
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
Mental health & behavior (25 active studies)
- The WeACT Program for Family Caregivers of People Living With Dementia · University of South Florida
- Libre Del Cigarrillo: Development of an mHealth Smoking Cessation App to Extend Reach of a Validated Smoking Cessation Intervention for Spanish-speaking Smokers · H. Lee Moffitt Cancer Center and Research Institute
Eye & vision (12 active studies)
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease · Phase 2 · Dompé Farmaceutici S.p.A
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
HIV / STI (8 active studies)
Pediatric (8 active studies)
Vaccines (7 active studies)
- A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease · Phase 3 · Shionogi
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age · Phase 3 · GlaxoSmithKline
Common conditions studied in Tampa
- Breast Cancer (22 active studies)
- Heart Failure (16 active studies)
- Colorectal Cancer (15 active studies)
- Acute Myeloid Leukemia (14 active studies)
- Cancer (13 active studies)
- Alzheimer Disease (12 active studies)
Leading research sponsors in Tampa
- H. Lee Moffitt Cancer Center and Research Institute
- University of South Florida
- AstraZeneca
- National Cancer Institute (NCI)
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Tampa?
There are approximately 1,061 recruiting clinical trials in Tampa, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tampa pay participants?
Most recruiting trials in Tampa compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tampa?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tampa?
The most common conditions under active study in Tampa include Breast Cancer (22), Heart Failure (16), Colorectal Cancer (15), Acute Myeloid Leukemia (14), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tampa?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tampa on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tampa?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tampa?
Recruiting research sites in Tampa include Moffitt Cancer Center, University of South Florida, Tampa General Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tampa right now?
The largest active categories in Tampa are Cancer & tumors (385), Neurology & pain (64), Cardiovascular (51). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.